Baisong Mei serves as Executive at Editas Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Baisong Mei has executed 10 insider transactions totaling $268.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 4, 2024 involved selling 518 shares valued at $1.8K.
Baisong Mei currently holds 133,895 shares of Editas Medicine, Inc. (EDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Baisong Mei has been a net seller of EDIT stock. They have purchased $0 and sold $268.5K worth of shares.
Baisong Mei's most recent insider trade was on Sep 4, 2024, when they sold 518 shares at $3.42 per share.
Get notified when new Form 4 filings are submitted
| $5.21 |
| Planned |
| Jun 4, 2024 | EDIT | $2.8K | Sale | 511 | $5.50 | Planned |
| Mar 4, 2024 | EDIT | $191.5K | Sale | 20,327 | $9.42 | Planned |
| Mar 2, 2024 | EDIT | $0 | Award | 19,458 | $N/A | Planned |
| Mar 2, 2024 | EDIT | $0 | Award | 19,457 | $N/A | Planned |
| Mar 2, 2024 | EDIT | $0 | Award | 50,900 | $N/A | Planned |
| Jul 19, 2023 | EDIT | $38.0K | Sale | 4,317 | $8.80 | Planned |
| Mar 2, 2023 | EDIT | $0 | Award | 18,000 | $N/A | Discretionary |
| Jul 18, 2022 | EDIT | $0 | Award | 58,372 | $N/A | Discretionary |